Plasma levels of atrial natriuretic peptide in hyperthyroidismWOOLF, A. S; MOULT, P. J. A.Clinical endocrinology (Oxford. Print). 1987, Vol 27, Num 6, pp 721-725, issn 0300-0664Article

The effect of α human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjectsWIJEYARATNE, C. N; MOULT, P. J. A.The Journal of clinical endocrinology and metabolism. 1993, Vol 76, Num 2, pp 343-346, issn 0021-972XArticle

Conn's syndrome due to a renin-responsive adrenal adenomaMILES, S. M; MOULT, P. J. A; HOFFBRAND, B. I et al.Journal of the Royal Society of Medicine. 1993, Vol 86, Num 5, issn 0141-0768, p. 294Article

Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in manGROSSMAN, A; MOULT, P. J. A; CUNNAH, D et al.Neuroendocrinology (Basel). 1986, Vol 42, Num 4, pp 357-360, issn 0028-3835Article

Clinical evaluation of lysuride in the management of hyperprolactinaemiaBOULOUX, P. M. G; BESSER, G. M; GROSSMAN, A et al.British medical journal (1857). 1987, Vol 294, Num 6583, pp 1323-1324, issn 0007-1447Article

Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndromeWOOLF, A. S; LYON, T. L; HOFFBRAND, B. I et al.Nephron. 1989, Vol 52, Num 3, pp 244-250, issn 0028-2766Article